|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gundem G, Van Loo P, Kremeyer B,
Alexandrov LB, Tubio JMC, Papaemmanuil E, Brewer DS, Kallio HML,
Högnäs G, Annala M, et al: The evolutionary history of lethal
metastatic prostate cancer. Nature. 520:353–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
US Preventive Services Task Force, ;
Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB,
Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, et al: Screening
for prostate cancer: US preventive services task force
recommendation statement. JAMA. 319:1901–1913. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng L, Zincke H, Blute ML, Bergstralh
EJ, Scherer B and Bostwick DG: Risk of prostate carcinoma death in
patients with lymph node metastasis. Cancer. 91:66–73. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fossa SD, Wiklund F, Klepp O, Angelsen A,
Solberg A, Damber JE, Hoyer M and Widmark A; The Scandinavian
Prostate Cancer Group-7 Investigators, : Ten- and 15-yr prostate
cancer-specific mortality in patients with nonmetastatic locally
advanced or aggressive intermediate prostate cancer, randomized to
lifelong endocrine treatment alone or combined with radiotherapy:
Final results of the scandinavian prostate cancer Group-7. Eur
Urol. 70:684–691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hay N: Reprogramming glucose metabolism in
cancer: Can it be exploited for cancer therapy? Nat Rev Cancer.
16:635–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Semenza GL: Hypoxia-inducible factors:
Coupling glucose metabolism and redox regulation with induction of
the breast cancer stem cell phenotype. EMBO J. 36:252–259. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olson AL and Pessin JE: Structure,
function, and regulation of the mammalian facilitative glucose
transporter gene family. Annu Rev Nutr. 16:235–256. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Cao Y, Zhang W, Bergmeier S, Qian
Y, Akbar H, Colvin R, Ding J, Tong L, Wu S, et al: A small-molecule
inhibitor of glucose transporter 1 downregulates glycolysis,
induces cell-cycle arrest, and inhibits cancer cell growth in vitro
and in vivo. Mol Cancer Ther. 11:1672–1682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu X and Gan B: lncRNA NBR2 modulates
cancer cell sensitivity to phenformin through GLUT1. Cell Cycle.
15:3471–3481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long Non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vrba L and Futscher BW: Epigenetic
silencing of lncRNA MORT in 16 TCGA cancer types. F1000Res.
7:2112018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee B, Mazar J, Aftab MN, Qi F, Shelley J,
Li JL, Govindarajan S, Valerio F, Rivera I, Thurn T, et al: Long
noncoding RNAs as putative biomarkers for prostate cancer
detection. J Mol Diagn. 16:615–626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu
F, Huang Y, Wu H, Li T and Li Y: Identification of
androgen-responsive lncRNAs as diagnostic and prognostic markers
for prostate cancer. Oncotarget. 7:60503–60518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sawayama H, Ishimoto T, Watanabe M,
Yoshida N, Baba Y, Sugihara H, Izumi D, Kurashige J and Baba H:
High expression of glucose transporter 1 on primary lesions of
esophageal squamous cell carcinoma is associated with hematogenous
recurrence. Ann Surg Oncol. 21:1756–1762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gwak H, Haegeman G, Tsang BK and Song YS:
Cancer-specific interruption of glucose metabolism by resveratrol
is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer
cells. Mol Carcinog. 54:1529–1540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng X, Han H, Liu GP, Ma YX, Pan RL,
Sang LJ, Li RH, Yang LJ, Marks JR, Wang W and Lin A: lncRNA wires
up Hippo and Hedgehog signaling to reprogramme glucose metabolism.
EMBO J. 36:3325–3335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun LY, Li XJ, Sun YM, Huang W, Fang K,
Han C, Chen ZH, Luo XQ, Chen YQ and Wang WT: lncRNA ANRIL regulates
AML development through modulating the glucose metabolism pathway
of AdipoR1/AMPK/SIRT1. Mol Cancer. 17:1272018. View Article : Google Scholar : PubMed/NCBI
|
